Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma
In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma ...
emjreviews.com6d
New Model Predicts Hepatocellular Carcinoma Risk in Patients with Noncirrhotic Hepatitis B
New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.